Windtree Announces Positive Topline Results from Its Phase 2 SEISMiC Study of Istaroxime in Early Cardiogenic Shock

3 years ago

Istaroxime significantly improved the systolic blood pressure profileWARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT),…

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders

3 years ago

Zachary Carpenter Zachary Carpenter, Ph.D., Founder and CEO of VantAIVantAI will pair its induced proximity platform with BI’s deep early…

Unite for Change Makes it Easy for Canadians to Take Action This Earth Day

3 years ago

Newly launched Unite for Change platform by CanadaHelps enables Canadians to drive meaningful change by supporting multiple charities through a…

CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”

3 years ago

Minimally Invasive, Outpatient Treatment Designed for Office or ClinicIRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas,…

Indicative offer to acquire 100% of the share capital of RAMSAY HEALTH CARE LIMITED (RAMSAY GENERALE DE SANTE’S Australian reference shareholder)

3 years ago

PRESS RELEASEParis, April 20th 2022 INDICATIVE OFFER TO ACQUIRE 100% OF THE SHARE CAPITAL OF RAMSAY HEALTH CARE LIMITED (RAMSAY…

Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults

3 years ago

First subject vaccinated in Phase 3 clinical trial of MVA-BN® RSV against respiratory syncytial virus (RSV) in older adultsTrial will…

Liisa Hurme appointed President and CEO of Orion Corporation as of 1 November 2022

3 years ago

PHOTO: Liisa Hurme (Photographer: Orion/Miika Kainu) Liisa HurmeORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION20 APRIL 2022 at 8:30 a.m.…

PIVLAZ (clazosentan) – Idorsia’s first commercial product – now available for patients in Japan

3 years ago

In Japan, PIVLAZ™ (clazosentan) 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction and cerebral ischemic…

Sienna Senior Living Inc. Announces Results From Annual and Special Meeting

3 years ago

MARKHAM, Ontario, April 19, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) is pleased…

Adverum Biotechnologies Announces Upcoming Data Presentations at ARVO 2022

3 years ago

Szilárd Kiss, M.D. to present new post-hoc analyses from the Phase 1 OPTIC Trial of ADVM-022 (AAV.7m8-aflibercept) in wet AMDREDWOOD…